T3	B-Entity	B-Entity	0	11	Angiotensin	Angiotensin	B-NP	NN	B-protein	3	SUB	B-protein
T3	I-Entity	I-Entity	12	14	II	II	I-NP	CD	I-protein	1	NMOD	I-protein
O	O	O	15	24	activates	activate	B-VP	VBZ	O	0	ROOT	O
O	O	O	25	28	the	the	B-NP	DT	O	11	NMOD	O
O	O	O	29	44	proinflammatory	proinflammatory	I-NP	JJ	B-protein	7	NMOD	B-protein
O	O	O	45	58	transcription	transcription	I-NP	NN	I-protein	7	NMOD	I-protein
O	O	O	59	65	factor	factor	I-NP	NN	I-protein	9	NMOD	I-protein
T4	B-Entity	B-Entity	66	73	nuclear	nuclear	B-NP	JJ	B-protein	9	NMOD	B-protein
T4	I-Entity	I-Entity	74	80	factor	factor	I-NP	NN	I-protein	11	NMOD	I-protein
T4	I-Entity	I-Entity	80	81	-	-	B-NP	HYPH	I-protein	11	NMOD	I-protein
T4	I-Entity	I-Entity	81	87	kappaB	kappaB	I-NP	NN	I-protein	3	OBJ	I-protein
O	O	O	88	90	in	in	B-PP	IN	O	11	NMOD	O
O	O	O	91	96	human	human	B-NP	JJ	B-cell_type	14	NMOD	B-cell_type
O	O	O	97	106	monocytes	monocyte	I-NP	NNS	I-cell_type	12	PMOD	I-cell_type
O	O	O	106	107	.	.	O	.	O	3	P	O

O	O	O	109	112	The	The	B-NP	DT	O	5	NMOD	O
O	O	O	113	118	renin	renin	I-NP	NN	B-protein	5	NMOD	B-protein
O	O	O	118	119	-	-	I-NP	HYPH	O	5	NMOD	O
T5	B-Entity	B-Entity	119	130	angiotensin	angiotensin	I-NP	NN	O	5	NMOD	O
O	O	O	131	137	system	system	I-NP	NN	O	6	SUB	O
O	O	O	138	141	may	may	B-VP	MD	O	0	ROOT	O
O	O	O	142	152	contribute	contribute	I-VP	VB	O	6	VC	O
O	O	O	153	155	to	to	B-PP	TO	O	7	VMOD	O
O	O	O	156	159	the	the	B-NP	DT	O	10	NMOD	O
O	O	O	160	172	pathogenesis	pathogenesis	I-NP	NN	O	8	PMOD	O
O	O	O	173	175	of	of	B-PP	IN	O	10	NMOD	O
O	O	O	176	191	atherosclerosis	atherosclerosis	B-NP	NN	O	11	PMOD	O
O	O	O	191	192	.	.	O	.	O	6	P	O

O	O	O	193	194	A	A	B-NP	DT	O	3	NMOD	O
O	O	O	195	201	common	common	I-NP	JJ	O	3	NMOD	O
O	O	O	202	209	feature	feature	I-NP	NN	O	9	SUB	O
O	O	O	210	212	of	of	B-PP	IN	O	3	NMOD	O
O	O	O	213	216	all	all	B-NP	DT	O	6	NMOD	O
O	O	O	217	223	stages	stage	I-NP	NNS	O	4	PMOD	O
O	O	O	224	226	of	of	B-PP	IN	O	6	NMOD	O
O	O	O	227	242	atherosclerosis	atherosclerosis	B-NP	NN	O	7	PMOD	O
O	O	O	243	245	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	246	258	inflammation	inflammation	B-NP	NN	O	9	PRD	O
O	O	O	259	261	of	of	B-PP	IN	O	10	NMOD	O
O	O	O	262	265	the	the	B-NP	DT	O	14	NMOD	O
O	O	O	266	272	vessel	vessel	I-NP	NN	O	14	NMOD	O
O	O	O	273	277	wall	wall	I-NP	NN	O	11	PMOD	O
O	O	O	277	278	.	.	O	.	O	9	P	O

O	O	O	279	282	The	The	B-NP	DT	O	5	NMOD	O
O	O	O	283	296	transcription	transcription	I-NP	NN	B-protein	5	NMOD	B-protein
O	O	O	297	303	factor	factor	I-NP	NN	I-protein	5	NMOD	I-protein
T6	B-Entity	B-Entity	304	311	nuclear	nuclear	B-NP	JJ	I-protein	5	NMOD	I-protein
T6	I-Entity	I-Entity	312	318	factor	factor	I-NP	NN	I-protein	7	NMOD	I-protein
T6	I-Entity	I-Entity	318	319	-	-	O	HYPH	O	7	P	O
T6	I-Entity	I-Entity	319	325	kappaB	kappaB	B-NP	NN	B-protein	13	SUB	B-protein
O	O	O	326	327	(	(	O	(	O	12	DEP	O
T7	B-Entity	B-Entity	327	329	NF	NF	B-NP	NN	B-protein	11	NMOD	B-protein
T7	I-Entity	I-Entity	329	330	-	-	B-NP	HYPH	I-protein	11	NMOD	I-protein
T7	I-Entity	I-Entity	330	336	kappaB	kappaB	I-NP	NN	I-protein	12	DEP	I-protein
O	O	O	336	337	)	)	O	)	O	7	NMOD	O
O	O	O	338	350	participates	participate	B-VP	VBZ	O	0	ROOT	O
O	O	O	351	353	in	in	B-PP	IN	O	13	VMOD	O
O	O	O	354	358	most	most	B-NP	JJS	O	17	NMOD	O
O	O	O	359	368	signaling	signaling	I-NP	NN	O	17	NMOD	O
O	O	O	369	377	pathways	pathway	I-NP	NNS	O	14	PMOD	O
O	O	O	378	386	involved	involve	B-VP	VBN	O	17	NMOD	O
O	O	O	387	389	in	in	B-PP	IN	O	18	VMOD	O
O	O	O	390	402	inflammation	inflammation	B-NP	NN	O	19	PMOD	O
O	O	O	402	403	.	.	O	.	O	13	P	O

O	O	O	404	408	This	This	B-NP	DT	O	2	NMOD	O
O	O	O	409	414	study	study	I-NP	NN	O	4	SUB	O
O	O	O	415	424	therefore	therefore	B-ADVP	RB	O	4	VMOD	O
O	O	O	425	433	examined	examine	B-VP	VBD	O	0	ROOT	O
O	O	O	434	437	the	the	B-NP	DT	O	6	NMOD	O
O	O	O	438	444	effect	effect	I-NP	NN	O	4	OBJ	O
O	O	O	445	447	of	of	B-PP	IN	O	6	NMOD	O
T8	B-Entity	B-Entity	448	459	angiotensin	angiotensin	B-NP	NN	B-protein	10	NMOD	B-protein
T8	I-Entity	I-Entity	460	461	(	(	O	(	I-protein	10	NMOD	I-protein
T8	I-Entity	I-Entity	461	464	ANG	ANG	B-NP	NN	I-protein	7	PMOD	I-protein
T8	I-Entity	I-Entity	464	465	)	)	O	)	I-protein	10	NMOD	I-protein
T8	I-Entity	I-Entity	466	468	II	II	B-NP	CD	I-protein	10	NMOD	I-protein
O	O	O	469	471	on	on	B-PP	IN	O	6	NMOD	O
T9	B-Entity	B-Entity	472	474	NF	NF	B-NP	NN	B-protein	16	NMOD	B-protein
T9	I-Entity	I-Entity	474	475	-	-	B-NP	HYPH	I-protein	16	NMOD	I-protein
T9	I-Entity	I-Entity	475	481	kappaB	kappaB	I-NP	NN	I-protein	17	NMOD	I-protein
O	O	O	482	492	activation	activation	I-NP	NN	O	13	PMOD	O
O	O	O	493	495	in	in	B-PP	IN	O	17	NMOD	O
O	O	O	496	505	monocytic	monocytic	B-NP	JJ	B-cell_type	20	NMOD	B-cell_type
O	O	O	506	511	cells	cell	I-NP	NNS	I-cell_type	25	NMOD	I-cell_type
O	O	O	511	512	,	,	O	,	O	25	P	O
O	O	O	513	514	a	a	B-NP	DT	O	25	NMOD	O
O	O	O	515	520	major	major	I-NP	JJ	O	25	NMOD	O
O	O	O	521	529	cellular	cellular	I-NP	JJ	O	25	NMOD	O
O	O	O	530	539	component	component	I-NP	NN	O	18	PMOD	O
O	O	O	540	542	of	of	B-PP	IN	O	25	NMOD	O
O	O	O	543	548	human	human	B-NP	JJ	O	28	NMOD	O
O	O	O	549	557	atheroma	atheroma	I-NP	NN	O	26	PMOD	O
O	O	O	557	558	,	,	O	,	O	4	P	O
O	O	O	559	561	by	by	B-PP	IN	O	4	VMOD	O
O	O	O	562	577	electrophoretic	electrophoretic	B-NP	JJ	O	34	NMOD	O
O	O	O	578	586	mobility	mobility	I-NP	NN	O	34	NMOD	O
O	O	O	587	592	shift	shift	I-NP	NN	O	34	NMOD	O
O	O	O	593	598	assay	assay	I-NP	NN	O	30	PMOD	O
O	O	O	598	599	.	.	O	.	O	4	P	O

T10	B-Entity	B-Entity	600	603	ANG	ANG	B-NP	NN	B-protein	7	SUB	B-protein
T10	I-Entity	I-Entity	604	606	II	II	I-NP	CD	I-protein	1	NMOD	I-protein
O	O	O	606	607	,	,	O	,	O	7	P	O
O	O	O	608	612	like	like	B-PP	IN	O	7	VMOD	O
T1	B-Protein	B-Protein	613	621	TNFalpha	TNFalpha	B-NP	NN	B-protein	4	PMOD	B-protein
O	O	O	621	622	,	,	O	,	O	7	P	O
O	O	O	623	629	caused	cause	B-VP	VBD	O	0	ROOT	O
O	O	O	630	635	rapid	rapid	B-NP	JJ	O	9	NMOD	O
O	O	O	636	646	activation	activation	I-NP	NN	O	7	OBJ	O
O	O	O	647	649	of	of	B-PP	IN	O	9	NMOD	O
T11	B-Entity	B-Entity	650	652	NF	NF	B-NP	NN	B-protein	13	NMOD	B-protein
T11	I-Entity	I-Entity	652	653	-	-	B-NP	HYPH	I-protein	13	NMOD	I-protein
T11	I-Entity	I-Entity	653	659	kappaB	kappaB	I-NP	NN	I-protein	10	PMOD	I-protein
O	O	O	660	662	in	in	B-PP	IN	O	9	NMOD	O
O	O	O	663	668	human	human	B-NP	JJ	B-cell_type	17	NMOD	B-cell_type
O	O	O	669	680	mononuclear	mononuclear	I-NP	JJ	I-cell_type	17	NMOD	I-cell_type
O	O	O	681	686	cells	cell	I-NP	NNS	I-cell_type	14	PMOD	I-cell_type
O	O	O	687	695	isolated	isolate	B-VP	VBN	O	17	NMOD	O
O	O	O	696	700	from	from	B-PP	IN	O	18	VMOD	O
O	O	O	701	711	peripheral	peripheral	B-NP	JJ	O	21	NMOD	O
O	O	O	712	717	blood	blood	I-NP	NN	O	19	PMOD	O
O	O	O	718	720	by	by	B-PP	IN	O	18	VMOD	O
O	O	O	721	727	Ficoll	Ficoll	B-NP	NN	O	25	NMOD	O
O	O	O	728	735	density	density	I-NP	NN	O	25	NMOD	O
O	O	O	736	744	gradient	gradient	I-NP	NN	O	22	PMOD	O
O	O	O	744	745	.	.	O	.	O	7	P	O

O	O	O	746	750	This	This	B-NP	DT	O	4	NMOD	O
T12	B-Entity	B-Entity	751	754	ANG	ANG	I-NP	NN	B-protein	4	NMOD	B-protein
T12	I-Entity	I-Entity	755	757	II	II	I-NP	CD	I-protein	4	NMOD	I-protein
O	O	O	758	764	effect	effect	I-NP	NN	O	5	SUB	O
O	O	O	765	768	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	769	776	blocked	block	I-VP	VBN	O	5	VC	O
O	O	O	777	779	by	by	B-PP	IN	O	6	VMOD	O
O	O	O	780	783	the	the	B-NP	DT	O	13	NMOD	O
T2	B-Protein	B-Protein	784	795	angiotensin	angiotensin	I-NP	NN	O	13	NMOD	O
T2	I-Protein	I-Protein	796	799	AT1	AT1	I-NP	NN	O	13	NMOD	O
T2	I-Protein	I-Protein	800	808	receptor	receptor	I-NP	NN	O	13	NMOD	O
O	O	O	809	819	antagonist	antagonist	I-NP	NN	O	13	NMOD	O
O	O	O	820	828	losartan	losartan	I-NP	NN	O	7	PMOD	O
O	O	O	828	829	.	.	O	.	O	5	P	O

O	O	O	830	841	Specificity	Specificity	B-NP	NN	O	11	SUB	O
O	O	O	842	844	of	of	B-PP	IN	O	1	NMOD	O
T13	B-Entity	B-Entity	845	848	ANG	ANG	B-NP	NN	B-protein	10	NMOD	B-protein
T13	I-Entity	I-Entity	849	851	II	II	I-NP	CD	I-protein	3	NMOD	I-protein
O	O	O	851	852	-	-	O	HYPH	O	3	P	O
O	O	O	852	859	induced	induce	B-NP	VBN	O	10	NMOD	O
T14	B-Entity	B-Entity	860	862	NF	NF	I-NP	NN	B-protein	9	NMOD	B-protein
T14	I-Entity	I-Entity	862	863	-	-	B-NP	HYPH	I-protein	9	NMOD	I-protein
T14	I-Entity	I-Entity	863	869	kappaB	kappaB	I-NP	NN	I-protein	10	NMOD	I-protein
O	O	O	870	880	activation	activation	I-NP	NN	O	2	PMOD	O
O	O	O	881	884	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	885	896	ascertained	ascertain	I-VP	VBN	O	11	VC	O
O	O	O	897	899	by	by	B-PP	IN	O	12	VMOD	O
O	O	O	900	910	supershift	supershift	B-NP	NN	O	17	NMOD	O
O	O	O	911	914	and	and	I-NP	CC	O	17	NMOD	O
O	O	O	915	926	competition	competition	I-NP	NN	O	17	NMOD	O
O	O	O	927	938	experiments	experiment	I-NP	NNS	O	13	PMOD	O
O	O	O	938	939	.	.	O	.	O	11	P	O

O	O	O	940	948	Moreover	Moreover	B-ADVP	RB	O	5	VMOD	O
O	O	O	948	949	,	,	O	,	O	5	P	O
T15	B-Entity	B-Entity	950	953	ANG	ANG	B-NP	NN	B-protein	5	SUB	B-protein
T15	I-Entity	I-Entity	954	956	II	II	I-NP	CD	I-protein	3	NMOD	I-protein
O	O	O	957	967	stimulated	stimulate	B-VP	VBD	O	0	ROOT	O
T16	B-Entity	B-Entity	968	970	NF	NF	B-NP	NN	B-protein	8	NMOD	B-protein
T16	I-Entity	I-Entity	970	971	-	-	B-NP	HYPH	I-protein	8	NMOD	I-protein
T16	I-Entity	I-Entity	971	977	kappaB	kappaB	I-NP	NN	I-protein	9	NMOD	I-protein
O	O	O	978	988	activation	activation	I-NP	NN	O	5	OBJ	O
O	O	O	989	991	in	in	B-PP	IN	O	9	NMOD	O
O	O	O	992	997	human	human	B-NP	JJ	B-cell_type	12	NMOD	B-cell_type
O	O	O	998	1007	monocytes	monocyte	I-NP	NNS	I-cell_type	10	PMOD	I-cell_type
O	O	O	1007	1008	,	,	B-PP	,	O	9	NMOD	O
O	O	O	1009	1012	but	but	I-PP	CC	O	13	PMOD	O
O	O	O	1013	1016	not	not	B-PP	RB	O	14	DEP	O
O	O	O	1017	1019	in	in	I-PP	IN	O	14	PMOD	O
O	O	O	1020	1031	lymphocytes	lymphocyte	B-NP	NNS	B-cell_type	16	PMOD	B-cell_type
O	O	O	1032	1036	from	from	B-PP	IN	O	17	NMOD	O
O	O	O	1037	1040	the	the	B-NP	DT	O	21	NMOD	O
O	O	O	1041	1045	same	same	I-NP	JJ	O	21	NMOD	O
O	O	O	1046	1057	preparation	preparation	I-NP	NN	O	18	PMOD	O
O	O	O	1057	1058	.	.	O	.	O	5	P	O

O	O	O	1059	1067	Together	Together	B-ADVP	RB	O	5	VMOD	O
O	O	O	1067	1068	,	,	O	,	O	5	P	O
O	O	O	1069	1072	the	the	B-NP	DT	O	4	NMOD	O
O	O	O	1073	1077	data	datum	I-NP	NNS	O	5	SUB	O
O	O	O	1078	1089	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	O	1090	1093	the	the	B-NP	DT	O	7	NMOD	O
O	O	O	1094	1101	ability	ability	I-NP	NN	O	5	OBJ	O
O	O	O	1102	1104	of	of	B-PP	IN	O	7	NMOD	O
O	O	O	1105	1108	the	the	B-NP	DT	O	12	NMOD	O
T17	B-Entity	B-Entity	1109	1119	vasoactive	vasoactive	I-NP	JJ	O	12	NMOD	O
T17	I-Entity	I-Entity	1120	1127	peptide	peptide	I-NP	NN	O	12	NMOD	O
T18	I-Entity	I-Entity	1128	1131	ANG	ANG	I-NP	NN	B-protein	8	PMOD	B-protein
T18	I-Entity	I-Entity	1132	1134	II	II	I-NP	CD	I-protein	12	NMOD	I-protein
O	O	O	1135	1137	to	to	B-VP	TO	O	15	VMOD	O
O	O	O	1138	1146	activate	activate	I-VP	VB	O	7	NMOD	O
O	O	O	1147	1159	inflammatory	inflammatory	B-NP	JJ	O	17	NMOD	O
O	O	O	1160	1168	pathways	pathway	I-NP	NNS	O	15	OBJ	O
O	O	O	1169	1171	in	in	B-PP	IN	O	17	NMOD	O
O	O	O	1172	1177	human	human	B-NP	JJ	B-cell_type	20	NMOD	B-cell_type
O	O	O	1178	1187	monocytes	monocyte	I-NP	NNS	I-cell_type	18	PMOD	I-cell_type
O	O	O	1187	1188	.	.	O	.	O	5	P	O

O	O	O	1189	1198	Copyright	Copyright	B-NP	NN	O	4	NMOD	O
O	O	O	1199	1203	1999	1999	I-NP	CD	O	4	NMOD	O
O	O	O	1204	1212	Academic	Academic	I-NP	NNP	O	4	NMOD	O
O	O	O	1213	1218	Press	Press	I-NP	NNP	O	0	ROOT	O
O	O	O	1218	1219	.	.	O	.	O	4	P	O
